| 产品名称: | HSB-2 |
|---|---|
| 商品货号: | TS259618 |
| <strong>Cell line </strong>: | HSB-2 |
| DSMZ no. : | TS259618 |
| Species : | confirmed as human with IEF of AST, MDH, PEP B |
| Cell type : | T cell leukemia |
| Origin : | established in 1966 from the peripheral blood of an 11-year-old boy with lymphosarcoma that had progressed to acute lymphoblastic leukemia (ALL); cell line was established and initially passaged in newborn hamsters; cells were described as carrying the t(1;7)(p34;q34) involving the LCK and TRB (LCK-TCRB) genes and a submicroscopic del(1)(p32) leading to the STIL-TAL1 (SIL-SCL) fusion gene; one of the oldest immature T cell lines, also known in the literature as CCRF-HSB-2 |
| Reference(s) : | 14345, 14346 |
| Biosafety level : | 1 |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | round to polygonal cells, growing singly or in dense clumps in suspension; image |
| Medium : | 90% RPMI 1640 + 10% h.i. FBS |
| Subculture : | seed out at ca. 0.3-0.4 x 106 cells/ml; maintain at ca. 0.4-1.0 x 106 cells/ml; split saturated culture 1:3 every 2-3 days; maximal density at ca. 1.3 x 106 cells/ml |
| Incubation : | at 37 °C with 5% CO2 |
| Doubling time : | ca. 25 hours |
| Harvest : | cell harvest of ca. 0.8 x 106 cells/ml |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | contamination was eliminated with BM-Cyclin (tiamulin & minocycline), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | CD2 -, cyCD3 +, smCD3 -, CD4 -, CD5 +, CD6 +, CD7 +, CD8 +, CD13 -, CD19 -, TCRalpha/beta -, TCRgamma/delta -; image |
| Fingerprint : | multiplex PCR of minisatellite markers revealed a unique DNA profile |
| Cytogenetics : | human pseudodiploid karyotype with 4% polyploidy - 46(42-46)<2n>XY, t(1;7)(p34;q35), carries t(1;7) effecting LCK-TRB (LCK-TCRB) fusion, resembles published karyotype |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |
| 产品名称: | HSB-2 |
|---|---|
| 商品货号: | TS259618 |
| <strong>Cell line </strong>: | HSB-2 |
| DSMZ no. : | TS259618 |
| Species : | confirmed as human with IEF of AST, MDH, PEP B |
| Cell type : | T cell leukemia |
| Origin : | established in 1966 from the peripheral blood of an 11-year-old boy with lymphosarcoma that had progressed to acute lymphoblastic leukemia (ALL); cell line was established and initially passaged in newborn hamsters; cells were described as carrying the t(1;7)(p34;q34) involving the LCK and TRB (LCK-TCRB) genes and a submicroscopic del(1)(p32) leading to the STIL-TAL1 (SIL-SCL) fusion gene; one of the oldest immature T cell lines, also known in the literature as CCRF-HSB-2 |
| Reference(s) : | 14345, 14346 |
| Biosafety level : | 1 |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | round to polygonal cells, growing singly or in dense clumps in suspension; image |
| Medium : | 90% RPMI 1640 + 10% h.i. FBS |
| Subculture : | seed out at ca. 0.3-0.4 x 106 cells/ml; maintain at ca. 0.4-1.0 x 106 cells/ml; split saturated culture 1:3 every 2-3 days; maximal density at ca. 1.3 x 106 cells/ml |
| Incubation : | at 37 °C with 5% CO2 |
| Doubling time : | ca. 25 hours |
| Harvest : | cell harvest of ca. 0.8 x 106 cells/ml |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | contamination was eliminated with BM-Cyclin (tiamulin & minocycline), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | CD2 -, cyCD3 +, smCD3 -, CD4 -, CD5 +, CD6 +, CD7 +, CD8 +, CD13 -, CD19 -, TCRalpha/beta -, TCRgamma/delta -; image |
| Fingerprint : | multiplex PCR of minisatellite markers revealed a unique DNA profile |
| Cytogenetics : | human pseudodiploid karyotype with 4% polyploidy - 46(42-46)<2n>XY, t(1;7)(p34;q35), carries t(1;7) effecting LCK-TRB (LCK-TCRB) fusion, resembles published karyotype |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |